The MarketWatch News Department was not involved in the creation of this content. -- Grünenthal acquires Valinor Pharma in an all-stock deal and becomes the owner of the global rights to Movantik(R) ...
Valinor Pharma said today it was purchased by German pharmaceutical company Grünenthal for about $250 million in upfront cash consideration. Chicago-based Valinor makes Movantik, a prescription ...
Parker Bennett is a graduate of Emerson College with more than 3 years of writing experience. He's been a fan and scholar of Tolkien's extended works for nearly his whole life, and is excited to be ...
Valinor’s academic collaborations with the Montgomery and Theis Labs will establish industry-standard benchmarks for assessing the clinical translatability of perturbation prediction models SALT LAKE ...
Grünenthal acquires Valinor Pharma in an all-stock deal and becomes the owner of the global rights to Movantik® (naloxegol) Valinor Pharma had owned Movantik since early 2023 and leveraged Apollo Care ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback